Knowledge, Attitude and Practice of Healthcare Workers Towards Availability of Antiretroviral Pre-Exposure Prohylaxis in Nigeria

A. Afe, A. Adetula, O. Peter, Oluwalusi Ebenezer, Omolola Olonisakin
{"title":"Knowledge, Attitude and Practice of Healthcare Workers Towards Availability of Antiretroviral Pre-Exposure Prohylaxis in Nigeria","authors":"A. Afe, A. Adetula, O. Peter, Oluwalusi Ebenezer, Omolola Olonisakin","doi":"10.14302/issn.2324-7339.jcrhap-18-2333","DOIUrl":null,"url":null,"abstract":"Introduction: The introduction of preexposure prophylaxis (PrEP) against incident HIV infection has changed the epidemiology of disease as continuous treatment with tenofovir and emtricitabine among high risk groups can reduce the relative risk for incident HIV infection by over 90%.However,despite the approved use of TDF+FTC, as a fixed dose combination of emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg, for oral PrEP since 2012 , it does not appear to have become widely accepted and in use among healthcare workers especially those in low income countries. Researches are therefore needed to consider the awareness and practice of health workers towards the availability of PrEP services in this part of the world. Healthcare workers are expected to be promoters of the use of PrEP services. Method: A cross sectional questionnaire-based study conducted in southern Nigerian over a 6 months period. Data were collected from 250 healthcare workers using interviewer-administered questionnaires. The data analysis was done using statistical package for the social sciences (SPSS) for windows version 20.0 software (SPSS Inc; Chicago, IL, USA). Frequency counts were generated for all variables and statistical test of significance was performed with chi-square test. Significance was fixed at P < 0.05 and highly significance if P < 0.01. Results: A high proportion of the respondents(>60%) were highly educated healthcare workers(majorly Nurses and medical doctors) and about half (55%) having at least 10yrs working experience in the health sector with most especially on the HIV program(>90%), majority (94%) of the health workers were aware about ARV pre-exposure prophylaxis but very few ( 6% )could give the standard definition for PrEP as the use of ARV drugs by HIV negative persons to prevent the acquisition of HIV.Most(67%) of them gave wrong definition for PrEP and worse still about one fifth (20%) had no idea what PrEP was all about. Most (70%) could not correctly identify all the ARV drugs in a standard PrEP regimen while about 35% had no idea at all of the approved ARVs used for PrEP. Though PrEP services was not available at any of the facilities where the respondents were working ,the approved drugs(TDF+FTC) for PrEP were available at about 40% of the health facilities(public and private) and 15% community pharmacies in the vicinity of the respondents . Only 60% of the respondents were willing to access PrEP service for themselves if indicated while 35% would not use such services even if it is indicated for reasons which include concern about adverse effects and safety.Awareness of PrEP was significantly associated with the ability of the healthcare workers to identify the correct ARV regimen, ARV dosages and also correct indication for PrEP. Awareness was also associated with the knowledge of the correct proven efficacy for PrEP(>95%) and high likelihood of seeing a patient placed on PrEP and willingness to use PrEP based on personal indication Conclusion: The level of awareness of PrEP among healthcare workers was very high at about 90% yet many(60%) could not give correct standard definitions of PrEP, PrEP ARV regimen, dosages and level of efficacy of PrEP. Also none of the respondent had PrEP services available either at their center or any known referral centers. This is unacceptable in a country with second highest HIV burden in the world and has adopted PrEP in her national HIV guideline with ongoing PrEP demonstration studies. The few healthcare workers who were able to mentioned this information were more likely to have seen a patient placed on PrEP and were more willing to use PrEP based on personal indication. Recommendations: There is need to deepen the and knowledge of PrEP among healthcare workers especially those in poor resource settings by engaging them through update courses outreach, educational resources, campaigns/seminars and workshops and various job aids. All healthcare service providers should be very comfortable to carry out HIV risk assessment of their clients and provide PrEP to those indicated directly or indirectly through referral","PeriodicalId":90584,"journal":{"name":"Journal of clinical research in HIV AIDS and prevention","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical research in HIV AIDS and prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14302/issn.2324-7339.jcrhap-18-2333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: The introduction of preexposure prophylaxis (PrEP) against incident HIV infection has changed the epidemiology of disease as continuous treatment with tenofovir and emtricitabine among high risk groups can reduce the relative risk for incident HIV infection by over 90%.However,despite the approved use of TDF+FTC, as a fixed dose combination of emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg, for oral PrEP since 2012 , it does not appear to have become widely accepted and in use among healthcare workers especially those in low income countries. Researches are therefore needed to consider the awareness and practice of health workers towards the availability of PrEP services in this part of the world. Healthcare workers are expected to be promoters of the use of PrEP services. Method: A cross sectional questionnaire-based study conducted in southern Nigerian over a 6 months period. Data were collected from 250 healthcare workers using interviewer-administered questionnaires. The data analysis was done using statistical package for the social sciences (SPSS) for windows version 20.0 software (SPSS Inc; Chicago, IL, USA). Frequency counts were generated for all variables and statistical test of significance was performed with chi-square test. Significance was fixed at P < 0.05 and highly significance if P < 0.01. Results: A high proportion of the respondents(>60%) were highly educated healthcare workers(majorly Nurses and medical doctors) and about half (55%) having at least 10yrs working experience in the health sector with most especially on the HIV program(>90%), majority (94%) of the health workers were aware about ARV pre-exposure prophylaxis but very few ( 6% )could give the standard definition for PrEP as the use of ARV drugs by HIV negative persons to prevent the acquisition of HIV.Most(67%) of them gave wrong definition for PrEP and worse still about one fifth (20%) had no idea what PrEP was all about. Most (70%) could not correctly identify all the ARV drugs in a standard PrEP regimen while about 35% had no idea at all of the approved ARVs used for PrEP. Though PrEP services was not available at any of the facilities where the respondents were working ,the approved drugs(TDF+FTC) for PrEP were available at about 40% of the health facilities(public and private) and 15% community pharmacies in the vicinity of the respondents . Only 60% of the respondents were willing to access PrEP service for themselves if indicated while 35% would not use such services even if it is indicated for reasons which include concern about adverse effects and safety.Awareness of PrEP was significantly associated with the ability of the healthcare workers to identify the correct ARV regimen, ARV dosages and also correct indication for PrEP. Awareness was also associated with the knowledge of the correct proven efficacy for PrEP(>95%) and high likelihood of seeing a patient placed on PrEP and willingness to use PrEP based on personal indication Conclusion: The level of awareness of PrEP among healthcare workers was very high at about 90% yet many(60%) could not give correct standard definitions of PrEP, PrEP ARV regimen, dosages and level of efficacy of PrEP. Also none of the respondent had PrEP services available either at their center or any known referral centers. This is unacceptable in a country with second highest HIV burden in the world and has adopted PrEP in her national HIV guideline with ongoing PrEP demonstration studies. The few healthcare workers who were able to mentioned this information were more likely to have seen a patient placed on PrEP and were more willing to use PrEP based on personal indication. Recommendations: There is need to deepen the and knowledge of PrEP among healthcare workers especially those in poor resource settings by engaging them through update courses outreach, educational resources, campaigns/seminars and workshops and various job aids. All healthcare service providers should be very comfortable to carry out HIV risk assessment of their clients and provide PrEP to those indicated directly or indirectly through referral
尼日利亚卫生保健工作者对抗逆转录病毒暴露前预防的知识、态度和做法
引言:针对偶发性HIV感染的预存预防(PrEP)的引入改变了疾病的流行病学,因为在高危人群中持续使用替诺福韦和恩曲他滨可以将偶发性艾滋病毒感染的相对风险降低90%以上。然而,尽管TDF+FTC已被批准使用,自2012年以来,作为恩曲他滨200 mg和富马酸替诺福韦300 mg的固定剂量组合,用于口服PrEP,它似乎没有被医护人员广泛接受和使用,尤其是低收入国家的医护人员。因此,需要进行研究,以考虑卫生工作者对世界这一地区PrEP服务可用性的认识和实践。医疗工作者有望成为PrEP服务使用的推动者。方法:在尼日利亚南部进行为期6个月的横断面问卷调查研究。使用访谈者管理的问卷从250名医护人员中收集数据。使用社会科学统计软件包(SPSS)for windows 20.0版软件(SPSS Inc;Chicago,IL,USA)进行数据分析。对所有变量进行频率计数,并用卡方检验进行显著性统计检验。显著性固定在P<0.05,极显著性为P<0.01。结果:高比例的受访者(>60%)是受过高等教育的医护人员(主要是护士和医生),约一半(55%)在卫生部门有至少10年的工作经验,尤其是在艾滋病毒项目中(>90%),大多数(94%)的卫生工作者知道抗逆转录病毒药物暴露前预防,但很少(6%)能将PrEP的标准定义为HIV阴性者使用抗逆转录病毒治疗药物来防止感染HIV。他们中的大多数(67%)对PrEP给出了错误的定义,更糟糕的是,约五分之一(20%)的人不知道PrEP是什么。大多数人(70%)无法正确识别标准PrEP方案中的所有抗逆转录病毒药物,而约35%的人完全不知道用于PrEP的所有批准的抗逆转录病毒。尽管受访者工作的任何机构都没有PrEP服务,经批准的PrEP药物(TDF+FTC)可在受访者附近约40%的卫生机构(公共和私人)和15%的社区药房获得。只有60%的受访者愿意在表示愿意的情况下自行使用PrEP服务,而35%的受访者即使表示出于担心不良影响和安全等原因也不会使用此类服务。对PrEP的认识与医护人员确定正确的抗逆转录病毒治疗方案、抗逆转录病毒药物剂量以及PrEP的正确适应症的能力显著相关。意识还与PrEP的正确有效性(>95%)、看到患者服用PrEP的高可能性以及基于个人适应症使用PrEP的意愿有关。结论:医护人员对PrEP的认识水平非常高,约为90%,但许多人(60%)无法给出PrEP、PrEP ARV方案的正确标准定义,PrEP的剂量和疗效水平。此外,没有一名受访者在其中心或任何已知的转诊中心提供PrEP服务。这在一个艾滋病毒负担居世界第二的国家是不可接受的,并且在其国家艾滋病毒指南中采用了PrEP,并正在进行PrEP示范研究。少数能够提到这一信息的医护人员更有可能看到患者服用了PrEP,并且更愿意根据个人适应症使用PrEP。建议:有必要通过更新课程外展、教育资源、运动/研讨会和讲习班以及各种工作辅助工具,让医护人员,特别是那些资源匮乏的医护人员,深入了解PrEP。所有医疗服务提供者都应该非常乐意对其客户进行艾滋病毒风险评估,并通过转诊直接或间接向患者提供PrEP
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信